Patrick Curtin, MD
Urology · Charleston, SCNPI 1639739360
Payments from drug & device makers
Across 88 payments — averaging $43.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$1K
- Johnson & Johnson$527
- Pfizer$478
- Teleflex LLC$317
- Procept Biorobotics Corporation$270
- Medtronic$209
- plus $940 from 13 others
What the payments were for
- Food & beverage$3,829100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 15 | $1,088 |
| Johnson & Johnson(2 entities) | 16 | $527 |
| Pfizer | 19 | $478 |
| Teleflex LLC | 5 | $317 |
| Procept Biorobotics Corporation | 2 | $270 |
| Medtronic | 2 | $209 |
| Astellas Pharma US Inc | 9 | $176 |
| Urogen Pharma, Inc. | 2 | $174 |
| Endo Pharmaceuticals Inc. | 1 | $138 |
| Sumitomo Pharma America, Inc. | 4 | $82 |
| Immunitybio, Inc. | 3 | $65 |
| Coloplast | 2 | $63 |
| Axonics, Inc. | 2 | $62 |
| Ferring Pharmaceuticals Inc. | 1 | $47 |
| Antares Pharma, Inc. | 1 | $44 |
| Telix Pharmaceuticals | 1 | $26 |
| AbbVie | 1 | $26 |
| Bayer | 1 | $20 |
| Intuitive Surgical | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- INTERSTIM$209
- AquaBeam Robotic System$189
- RYBREVANT$146
- CARVYKTI$146
- XIAFLEX$138
- JELMYTO$125
- XTANDI$114
- GreenLight XPS$111
- GENERAL KIDNEY STONE DISEASE$107
- LithoVue$101
- AMS 700$101
How this compares
$3,829 in reported general payments places this provider in the 50th percentile of 196 urology providers in South Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Tamsulosin Hcl | 42 | $1,056 |
| Finasteride | 35 | $934 |
| Ondansetron Hcl | 56 | $148 |
| Ciprofloxacin Hcl | 18 | $66 |
| Oxycodone Hcl | 36 | $57 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 20 | $53 |
| Oxybutynin Chloride | 14 | $53 |
Paid to pharmacies, not to this prescriber.
Other urology in Charleston
- Sandip PrasadCharleston$2.4M
- Stephen SavageCharleston$2.1M
- Thomas KeaneCharleston$281K
- Matvey TsivianCharleston$101K
- Robert GrubbCharleston$90K
- Paul WombleCharleston$88K
- Ian MarshallCharleston$60K
- John BrittonCharleston$15K
- John AdamsCharleston$15K
- Bradley SteeleCharleston$12K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.